J.W. Cole Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

J.W. Cole Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$345K	Buy	2,914 +2	+0.1%	+$216	0.01%	1201
2026 Q1	$302K	Buy	2,912 +2	+0.1%	+$211	0.01%	628
2025 Q4	$304K	Buy	2,910 +131	+5%	+$13.2K	0.01%	1094
2025 Q3	$257K	Sell	2,779 -114	-4%	-$9.98K	﹤0.01%	1304
2025 Q2	$231K	Sell	2,893 -23	-0.8%	-$1.83K	﹤0.01%	1286
2025 Q1	$253K	Buy	+2,916	New	+$248K	0.01%	1048
2021 Q3	–	Sell	-3,159	Closed	-$254K	–	672
2021 Q2	$254K	Buy	3,159 +205	+7%	+$16.3K	0.02%	629
2021 Q1	$233K	Buy	+2,954	New	+$230K	0.02%	586
2020 Q4	–	Sell	-4,787	Closed	-$306K	–	821
2020 Q3	$306K	Buy	+4,787	New	+$313K	0.02%	538

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

J.W. Cole Advisors's PJP Position: Q2 2026 in Review

J.W. Cole Advisors increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.07% in Q2 2026, buying an estimated $216 and bringing the position to 2,914 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #1201.

J.W. Cole Advisors first reported a position in PJP in Q3 2020 and has held it in 9 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

J.W. Cole Advisors held 2,914 shares of Invesco Pharmaceuticals ETF worth $345K as of Q2 2026.
J.W. Cole Advisors bought 2 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $216.
Invesco Pharmaceuticals ETF made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1201 holding.
J.W. Cole Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2020 and has held it in 9 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.